Elisabeth Heath

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Specialty Not Specified)
    Ineligible company:
    Oncolys
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Specialty Not Specified)
    Ineligible company:
    Agensys
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Specialty Not Specified)
    Ineligible company:
    Merck
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Specialty Not Specified)
    Ineligible company:
    Zenith
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company:
    Seattle Genetics
    Date added:
    Date updated:
    04/13/2022
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Specialty Not Specified)
    Ineligible company:
    Sanofi
    Date added:
    Date updated:
    04/13/2022
Return to Update Series (2023) Lesson 12: Adjuvant and Early Salvage Therapy Recommendations Following Radical Surgery in Urologic Cancers